Artificial blood could reduce preventable deaths in settings where limited supply costs millions of lives in low-income ...

Rusfertide (Protagonist Therapeutics/Takeda Pharmaceuticals) — administered as a once-weekly subcutaneous injection — also helped maintain red blood cell levels at acceptable levels, reduced ...